A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...

Dame Judi Dench, celebrated for her iconic roles and commanding presence on screen, has offered a candid update on her health ...

Developed by Soliddd Corp, this innovative technology, showcased at CES 2025, represents the “first true vision correction” ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Physical changes are a normal byproduct of aging. Gray hairs and less elastic skin that contributes to wrinkles may be among ...

The following is a summary of “Neuroretinal and RPE changes and susceptibility to Age-Related Macular Degeneration: insights ...

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...